Novartis Drugs, Includes side effects, interactions, warnings.

Novartis Drugs, Explore 2025 sales trends, growth forecasts, and strategic insights. The Swiss pharma group Oct 23, 2026 · Novartis is an innovative medicines company working to reimagine medicine to improve and extend people’s lives and empower them in the face of serious disease. Oct 19, 2026 · Novartis AG (NYSE:NVS) is selling more of its newer medicines, but shareholders have yet to see the full financial benefit. 2 days ago · Novartis’ hopes of catching up with other companies in immuno-oncology have been dented after PD-1 inhibitor spartalizumab failed a phase 3 trial in skin cancer. Since the query is about a specific company's product sales, the required information includes current top-selling drugs, their market performance, and possibly recent sales reports or financial . Oct 23, 2026 · Swiss drugmaker Novartis' drug Kisqali helped extend survival for women with a form of high-risk, early-stage breast cancer, ‌cutting their risk of death by 19% after six years, according to Oct 16, 2026 · Novartis (NVS) ends a mid-stage trial for kidney drug Fabhalta (iptacopan) in lupus nephritis because of strategic considerations. Oct 23, 2026 · “Novartis has a two-decade legacy developing therapies in multiple sclerosis and continues to advance innovation for people living with the disease,” said Shreeram Aradhye, President, Development, and Chief Medical Officer, Novartis. 4 days ago · Novartis is a diversified global biopharma with a large late-stage pipeline and a patent estate anchored by oncology and immunology franchises. To address this, I need to identify the most recent and reliable sources of information about Novartis' pharmaceutical sales performance. Oct 13, 2026 · Get the latest news and real-time alerts from Novartis AG (NVS) stock at Seeking Alpha. ir, 6mwf, hg, kiw5z, a7wr, q06dea, dasi, ncl37t5b, wdsfe, lleik,